Large-scale testing (Phase 3)Study completedNCT04494438What this trial is testingRituximab for Idiopathic Nephrotic SyndromeWho this might be right forIdiopathic Nephrotic Syndrome Istituto Giannina Gaslini 30
Testing effectiveness (Phase 2)WithdrawnNCT05599815What this trial is testingPart 1 - A Clinical Trial in Patients With Frequently Relapsing and Steroid-Dependent Nephrotic SyndromeWho this might be right forNephrotic Syndrome Aldeyra Therapeutics, Inc.
Not applicableActive Not RecruitingNCT02194582What this trial is testingGenetic Causes of FSGS, Nephrotic Syndrome, or Kidney FailureWho this might be right forFocal Segmental GlomerulosclerosisNephrotic SyndromeEnd Stage Renal Disease+2 more Beth Israel Deaconess Medical Center 2,050
Not applicableLooking for participantsNCT05505500What this trial is testingInterview Study of Adult and Child Patients and Parents of Children With Swelling Due to Nephrotic Syndrome.Who this might be right forFluid OverloadGlomerulosclerosis, Focal SegmentalEdema+10 more University of Michigan 150
Not applicableNot Yet RecruitingNCT07010250What this trial is testingEpithelial Dysmetabolism and Renal Fibrosis in ANCA VasculitisWho this might be right forANCA Associated VasculitisExtramembranous GlomerulopathyNephrotic Syndrome, Minimal Change+4 more Assistance Publique - Hôpitaux de Paris 146
Testing effectiveness (Phase 2)Study completedNCT02592798What this trial is testingPilot Study to Evaluate the Safety and Efficacy of Abatacept in Adults and Children 6 Years and Older With Excessive Loss of Protein in the Urine Due to Either Focal Segmental Glomerulosclerosis (FSGS) or Minimal Change Disease (MCD)Who this might be right forNephrotic SyndromeFocal Segmental GlomerulosclerosisMinimal Change Disease Bristol-Myers Squibb 36
Testing effectiveness (Phase 2)Looking for participantsNCT06466135What this trial is testingStudy of WAL0921 in Patients With Glomerular Kidney DiseasesWho this might be right forDiabetic NephropathiesPrimary Focal Segmental GlomerulosclerosisMinimal Change Disease+2 more Walden Biosciences 96
Testing effectiveness (Phase 2)Looking for participantsNCT06500702What this trial is testingEvaluate the Efficacy and Safety of Frexalimab, Brivekimig, or Rilzabrutinib in Participants Aged 16 to 75 Years With Primary Focal Segmental Glomerulosclerosis or Minimal Change DiseaseWho this might be right forFocal Segmental GlomerulosclerosisGlomerulonephritis Minimal Lesion Sanofi 84
Not applicableLooking for participantsNCT04571658What this trial is testingNEPTUNE Match StudyWho this might be right forNephrotic Syndrome in ChildrenFocal Segmental GlomerulosclerosisMinimal Change Disease+6 more University of Michigan 375
Large-scale testing (Phase 3)Looking for participantsNCT05914155What this trial is testingClinical Study of Rituximab for the Treatment for Idiopathic Membranous Nephropathy with Nephrotic SyndromeWho this might be right forGlomerulonephritis, MembranousNephrotic Syndrome，Idiopathic Shoichi Maruyama MD PhD 88
Post-approval studies (Phase 4)Study completedNCT01185197What this trial is testingMyfortic® for Minimal Change Nephrotic Syndrome (MCNS): a Randomized StudyWho this might be right forNephrosis, Lipoid The University of Hong Kong 20
Not applicableLooking for participantsNCT04207580What this trial is testingA National Prospective Cohort of Patients With Idiopathic Nephrotic Syndrome Beginning in Childhood.Who this might be right forIdiopathic Nephrotic Syndrome University Hospital, Limoges 1,180
Not applicableNot Yet RecruitingNCT06443034What this trial is testingPredictive Determinants of Nephrotic Syndrome Remission in Patients With At-risk Polymorphism of APOL1Who this might be right forNephrotic SyndromeFocal Segmental GlomerulosclerosisAPOL1 Associated Kidney Disease Assistance Publique - Hôpitaux de Paris 124
Post-approval studies (Phase 4)Study completedNCT01129284What this trial is testingTreatment of Resistant Nephrotic Syndrome With ACTH Gel (ACTHAR)Who this might be right forTreatment Resistant Nephrotic Syndrome Columbia University 15
Not applicableUnknownNCT03786263What this trial is testingCHILDNEPH The Canadian Childhood Nephrotic Syndrome StudyWho this might be right forNephrotic Syndrome in ChildrenNephrotic Syndrome, Minimal ChangeNephrotic Syndrome，Idiopathic University of Calgary 400
Large-scale testing (Phase 3)Study completedNCT01268033What this trial is testingEfficacy of Rituximab For the Treatment of Calcineurin Inhibitors Dependent Nephrotic Syndrome During ChildhoodWho this might be right forChildhood Idiopathic Nephrotic Syndrome University Hospital, Limoges 26
Not applicableLooking for participantsNCT03929887What this trial is testingKOrea Renal Biobank NEtwoRk System TOward NExt-generation AnalysisWho this might be right forGlomerular DiseaseMinimal Change DiseaseIgA Nephropathy+4 more Seoul National University Hospital 3,000
Not applicableLooking for participantsNCT05650619What this trial is testingRecurrence Post-transplant Observational Study in Focal Segmental Glomerulosclerosis and Minimal Change DiseaseWho this might be right forFocal Segmental GlomerulosclerosisMinimal Change DiseaseFSGS+1 more University of Michigan 300
Post-approval studies (Phase 4)Study completedNCT00982072What this trial is testingTacrolimus Versus Prednisolone for the Treatment of Minimal Change DiseaseWho this might be right forMinimal Change Disease Imperial College Healthcare NHS Trust 52
Not applicableStudy completedNCT00255398What this trial is testingKidney Disease BiomarkersWho this might be right forKidney DiseaseGlomerular DiseaseIdiopathic Nephrotic Syndrome+2 more National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 25